Sep 2013 to Dec 2013CitiBank New York, NY Technology Analyst InterniCIMS, inc Matawan, NJ Software Engineer
Education:
New York University Sep 2012 to May 2014 Master of Computer ScienceBeijing University of Posts&Telecommunication Sep 2008 to Jun 2012 Bachelor of Computer Science in computing
A Citi Company New York, NY Sep 2008 to May 2009 Financial InternChina Construction Bank Xi'an, China Sep 2006 to May 2007 Banking and Information System InternSitong Construction Material Company Baoshan, China Jun 2006 to Aug 2006 Marketing Intern
Education:
St.John's University New York, NY Jan 2008 to Jan 2011 MBA in FinanceXian University of Science and Technology Xi'an, Shangxi Jan 2003 to Jan 2007 Bachelor of Information Management in Management & Information Systems
Skills:
Technical: Microsoft Excel, Word, PowerPoint, Access, VB, VBA, C, Factset, SQL, S-Plus, SPSS, Bloomberg System Language: Bilingual in Chinese and English
Citic Group USA Office New York, NY Feb 2012 to Apr 2012 Administrative AssistantSurfind Alliance New York, NY Dec 2011 to Jan 2012 Marketing InternNorth Xinda Shanxi Taiyuan, CN Sep 2008 to Aug 2010 ConsultantDarenfa Shopping Mall Yantai, CN Mar 2009 to Apr 2009
Education:
Stevens Institute of Technology Hoboken, NJ May 2012 Master of Science in ManagementChina Agricultural University Jul 2010 Bachelor of Management in Agriculture and Forestry Economic Management
Process For The Preparation Of Tert-Butyl 4-((2S,5R)-6-(Benzyloxy)-7-Oxo-1,6-Diazabicyclo[3.2.1]Octane-2-Carboxamido)Piperidine-1-Carboxylate And Analogs Thereof
- Rahway NJ, US Nobuyoshi Yasuda - Mountainside NJ, US Lu Yang - San Diego CA, US Artis Klapars - Edison NJ, US Kevin R. Campos - Berkeley Heights NJ, US Mikhail Reibarkh - Cranford NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07D 471/08 C07F 7/18 C07F 7/10
Abstract:
The present invention relates to processes for preparing compounds of Formula I. Such compounds include intermediates in the manufacture of 7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide beta-lactamase inhibitors such as (2S,5R)-7-oxo-N-5 piperidin-4-yl-6-(sulfoxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide. The present invention also relates to novel intermediates formed i these processes. The present invention relates to a process for preparing a compound of Formula I or a pharmaceutically acceptable salt thereof.